Who makes Duphastone?

Duphastone is developed by Konya Meram State Hospital.

What development phase is Duphastone in?

Duphastone is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Duphastone

Konya Meram State Hospital · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	Duphastone
Sponsor	Konya Meram State Hospital
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist Protocols in Women With Polycystic Ovarian Syndrome
Comparison of Dydrogesterone and Micronized Progesterone Treatments in the Treatment of Threatened Miscarriage. (PHASE4)
Dydrogesterone Versus Intravaginal Progesterone in the Luteal Phase Support (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Duphastone CI brief — competitive landscape report
Duphastone updates RSS · CI watch RSS
Konya Meram State Hospital portfolio CI